Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers

This study is an open-label, multicenter Phase IIa trial to evaluate the efficacy and safety of SC-101 monotherapy in patients with locally advanced or metastatic malignant tumors who are positive for NECTIN4 gene amplification.

Participants needed: 120
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Tianjin ConjuStar Biologics Co., Ltd.Updated: Sep 11, 2025
Eligibility criteria

Not listed

Read more
Status: Recruiting

Study of SC-102 in Patients With Advanced Solid Tumors

This study will evaluate the safety, PK profile, and anti-cancer efficacy of SC-102 in subjects with advanced solid tumors

Participants needed: 120
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Tianjin ConjuStar Biologics Co., Ltd.Updated: Jul 29, 2025Locations: 1
Eligibility criteria

Subjects voluntarily agree to participate in the study and sign the Informed Con... [+9]

History of other malignancy(ies) within 3 years before signing the ICF, except f... [+14]

Read more
Status: Recruiting

Study SC-101 in Subjects With Advanced Malignancies

This study will evaluate the safety, pharmacokinetics, and anti-cancer efficacy of SC-101 in subjects with advanced or metastatic solid tumors.

Participants needed: 100
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Tianjin ConjuStar Biologics Co., Ltd.Updated: Jul 29, 2025Locations: 5
Eligibility criteria

Subjects voluntarily agree to participate in the study and sign the Informed Con... [+10]

History of other malignancy(ies) within 3 years before signing the ICF, except f... [+20]

Read more